Broad misappropriation of developmental splicing profile by cancer in multiple organs
Open Access
- 12 December 2022
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-18
Abstract
Oncogenesis mimics key aspects of embryonic development. However, the underlying mechanisms are incompletely understood. Here, we demonstrate that the splicing events specifically active during human organogenesis, are broadly reactivated in the organ-specific tumor. Such events are associated with key oncogenic processes and predict proliferation rates in cancer cell lines as well as patient survival. Such events preferentially target nitrosylation and transmembrane-region domains, whose coordinated splicing in multiple genes respectively affect intracellular transport and N-linked glycosylation. We infer critical splicing factors potentially regulating embryonic splicing events and show that such factors are potential oncogenic drivers and are upregulated specifically in malignant cells. Multiple complementary analyses point to MYC and FOXM1 as potential transcriptional regulators of critical splicing factors in brain and liver. Our study provides a comprehensive demonstration of a splicing-mediated link between development and cancer, and suggest anti-cancer targets including splicing events, and their upstream splicing and transcriptional regulators.Keywords
All Related Versions
Funding Information
- National Cancer Institute - Intramural research program
This publication has 128 references indexed in Scilit:
- MBNL proteins repress ES-cell-specific alternative splicing and reprogrammingNature, 2013
- Molecular insights into the regulation of iron metabolism during the prenatal and early postnatal periodsCellular and Molecular Life Sciences, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- WD40 Repeat Propellers Define a Ubiquitin-Binding Domain that Regulates Turnover of F Box ProteinsMolecular Cell, 2010
- A Myc Network Accounts for Similarities between Embryonic Stem and Cancer Cell Transcription ProgramsCell, 2010
- An ESRP‐regulated splicing programme is abrogated during the epithelial–mesenchymal transitionThe EMBO Journal, 2010
- An Alternative Splicing Network Links Cell-Cycle Control to ApoptosisCell, 2010
- ESRP1 and ESRP2 Are Epithelial Cell-Type-Specific Regulators of FGFR2 SplicingMolecular Cell, 2009
- Role of S-nitrosylation in apoptosis resistance and carcinogenesisNitric Oxide, 2008
- Sox2: a possible driver of the basal-like phenotype in sporadic breast cancerLaboratory Investigation, 2007